FORT WORTH, Texas—Alcon has announced that Timothy C. Stonesifer is joining the company as its new senior vice president and chief financial officer. He will assume his role on April 9, 2019, following Alcon’s separation from Novartis, as reported by VMAIL. Stonesifer will replace Alcon’s current CFO, David Murray, who has decided to remain with Novartis and return to Europe. Before taking on this role, Stonesifer served as executive vice president and CFO at Hewlett Packard Enterprises, where he executed two spin merge transactions, and completed 11 acquisitions, among other accomplishments.

David Endicott, chief executive officer at Alcon, stated, “Tim joins us at an exciting time as we become an independent organization and the world’s leading eyecare device company. He is an outstanding addition to our leadership team, bringing extraordinary financial acumen and deep experience in capital markets transactions.

"On behalf of the management team and the entire company, I would like to thank David Murray for his significant contributions to Alcon over the past 4 years. David has been transparent about wanting to minimize his commute between Geneva and Fort Worth and we certainly respect his decision. He has worked tirelessly to drive transformation across the company, developing a strong foundation for our financial and business processes and systems that will allow us to operate from a position of strength as a public standalone company. We wish David all the best in his future with Novartis.”

Stonesifer said, “I am excited to join the exceptional team at Alcon. For more than 70 years, Alcon has been synonymous with eyecare. We share a passion for serving customers and a vision for delivering innovative products that will continue to shape the industry while driving profitable growth.”